Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambrisentan PK/PD in Fontan Patients
NCT02080637Phase 2Completed
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ambrisentan in single ventricle heart defect (SV). Started Jul 2015; status: completed.
02
Drugs
ambrisentan
03
Conditions
single ventricle heart defect (SV)
Beyond the preview
Go deeper on NCT02080637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080637.